New tests recommended by the WHO can address TB cases with no or few symptoms more quickly and improve access to life-saving treatment.

Led by YSPH and partners at CIDEIM at Icesi University, the research team conducted the study in Cali, Colombia.

Patients with uveitis exhibited lower risk for TB with adalimumab therapy, though the risk was not completely eliminated.

The test, targeted at adults with asymptomatic tuberculosis, detected the infectious disease in the blood up to 18 months ...

Systemic inefficiencies, like the gender gap and siloed healthcare, hinder the fight against tuberculosis, despite scientific advances ...

Health leaders in Central California say they are consistently testing and treating latent cases of tuberculosis. According to the California Department of Public Health, Fresno County reported 50 ...

Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until ...

Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people each year and caused an | Genetics And Genomics ...

Data from the Epidemiology Bureau’s Integrated Tuberculosis Information System showed that 101,807 TB cases have been ...

Last week, activists and patients won a breakthrough in the fight against the world’s deadliest infectious disease: tuberculosis. Cepheid, a medical equipment manufacturer owned by the multinational ...

The new government TB dashboard is a step forward for transparency and accountability in South Africa's response to the ...